Osteoboost

Therapeutic Devices · Redwood City, CA · Founded 2014 · Privately Held (backing)

Developer of a medical device designed to provide relief from osteopenia. Osteoboost is based in Redwood City, CA and was founded in 2014. It was valued at $45 million at its later-stage round in Apr 2026, the last priced event on record. It has raised $17.8 million across 1 recorded round; the latest was an accelerator round in Jan 2024.

PMV mark · valuation
$45.0M
Oct 2026
Priced at
its later-stage round
Apr 2026
Total raised
$17.8M
Last round
Accelerator/Incubator
Jan 2024

Osteoboost key facts

as of Oct 2026
  • Developer of a medical device designed to provide relief from osteopenia.
  • Osteoboost is valued at approximately $45.0M as of Oct 2026, set at its later-stage round, Apr 2026; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $17.8M across 1 recorded rounds; the latest was Accelerator/Incubator in Jan 2024.
  • Notable investors include MedTech Innovator, Springboard Enterprises, Matter (Consulting Services (B2B)), Band of Angels, Good Growth Capital — 20 tracked in total.
  • 1 investment vehicle was formed to buy Osteoboost shares in the last 12 months, reporting $600K sold to 10 investors, per SEC Form D filings.
  • Status: Privately Held (backing).
PrivateMarketView mark
MEDIUM confidence
$45.0M

Valued at $45.0M at its later-stage round, Apr 2026. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Osteoboost with a free account
  • ·The complete investor list: 20 names
  • ·Watch Osteoboost: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Osteoboost funding rounds

1 rounds
Jan 2024Accelerator/Incubator—▮

Vehicles formed to buy Osteoboost shares

secondary demand · SEC Form D filings

In the last 12 months, 1 investment vehicle were formed to buy Osteoboost shares, reporting $600K sold to 10 investors. Most recent filing May 2026.

The vehicle list — each sponsor, filing date, amount sold and investor count — is a Pro table. Unlock the 1 vehicle →

Membership and data by Private Market View

Osteoboost valuation

Osteoboost was valued at $45 million at its later-stage round in Apr 2026. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Osteoboost raised?

Osteoboost has raised $17.8 million in total; 1 of its rounds is on record. The most recent was an accelerator round in Jan 2024.

Institutional holders and vehicles

In the last 12 months, 1 investment vehicle was formed to buy Osteoboost shares, reporting $600,000 sold to 10 investors, per SEC Form D filings (most recent May 2026).

Osteoboost investors

20 investors are on record for Osteoboost, including MedTech Innovator, Springboard Enterprises, Matter (Consulting Services (B2B)) and Band of Angels.

Comparable companies

Comparable therapeutic devices names by valuation on PrivateMarketView: Materna Medical ($110 million), Luminate Medical ($74.5 million) and NasaClip ($16 million).

About Osteoboost

Developer of a medical device designed to provide relief from osteopenia. The company offers precise, sensor-calibrated vibration delivery, integrated tracking and reminders, and at-home usability to slow bone density loss in postmenopausal women with osteopenia through a wearable vibration therapy device, enabling patients suffering from bone mass problems to access an effective non-drug intervention.

Industry
Therapeutic Devices
Sector
Healthcare
HQ
Redwood City, CA, United States
Founded
2014
Employees
12
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.